Cargando…

Prospective surveillance of colonization and disease by methicillin-resistant Staphylococcus aureus (MRSA) at a European pediatric cancer center

PURPOSE: Children and adolescents undergoing treatment for cancer or allogeneic hematopoietic cell transplantation are at increased risk for methicillin-resistant Staphylococcus aureus (MRSA). We therefore examined the occurrence and outcome of MRSA colonization and infection in patients of a large...

Descripción completa

Detalles Bibliográficos
Autores principales: Füller, Miriam A., Kampmeier, Stefanie, Wübbolding, Anna M., Grönefeld, Judith, Kremer, Almut, Groll, Andreas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385780/
https://www.ncbi.nlm.nih.gov/pubmed/35589879
http://dx.doi.org/10.1007/s00520-022-07140-0
_version_ 1784769663627952128
author Füller, Miriam A.
Kampmeier, Stefanie
Wübbolding, Anna M.
Grönefeld, Judith
Kremer, Almut
Groll, Andreas H.
author_facet Füller, Miriam A.
Kampmeier, Stefanie
Wübbolding, Anna M.
Grönefeld, Judith
Kremer, Almut
Groll, Andreas H.
author_sort Füller, Miriam A.
collection PubMed
description PURPOSE: Children and adolescents undergoing treatment for cancer or allogeneic hematopoietic cell transplantation are at increased risk for methicillin-resistant Staphylococcus aureus (MRSA). We therefore examined the occurrence and outcome of MRSA colonization and infection in patients of a large European pediatric cancer center. METHODS: In a prospective observational cohort study conducted between 2007 and 2018, nasopharyngeal swabs for culture of MRSA were obtained from all admitted patients. The primary endpoint of the study was the colonization rate over time. Secondary endpoints included genetic relatedness of isolates, time burden of isolation measures, and results of decolonization efforts. RESULTS: During the study period, MRSA screening identified 34 colonized patients (median age: 10 years; range: 0–21) without trends over time. MRSA colonization was associated with the presence of classical risk factors. There was no molecular evidence of patient-to-patient transmission. A standard MRSA eradication regimen led to a lasting eradication of the organism in 26 of 34 patients. MRSA infection occurred in two patients with no associated fatalities. CONCLUSION: Prospective monitoring revealed low rates of MRSA colonization and infection at our center. These low rates and the absence of patient-to-patient transmission support the effectiveness of the management bundle of MRSA identification, isolation, and decolonization. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-022-07140-0.
format Online
Article
Text
id pubmed-9385780
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-93857802022-08-19 Prospective surveillance of colonization and disease by methicillin-resistant Staphylococcus aureus (MRSA) at a European pediatric cancer center Füller, Miriam A. Kampmeier, Stefanie Wübbolding, Anna M. Grönefeld, Judith Kremer, Almut Groll, Andreas H. Support Care Cancer Original Article PURPOSE: Children and adolescents undergoing treatment for cancer or allogeneic hematopoietic cell transplantation are at increased risk for methicillin-resistant Staphylococcus aureus (MRSA). We therefore examined the occurrence and outcome of MRSA colonization and infection in patients of a large European pediatric cancer center. METHODS: In a prospective observational cohort study conducted between 2007 and 2018, nasopharyngeal swabs for culture of MRSA were obtained from all admitted patients. The primary endpoint of the study was the colonization rate over time. Secondary endpoints included genetic relatedness of isolates, time burden of isolation measures, and results of decolonization efforts. RESULTS: During the study period, MRSA screening identified 34 colonized patients (median age: 10 years; range: 0–21) without trends over time. MRSA colonization was associated with the presence of classical risk factors. There was no molecular evidence of patient-to-patient transmission. A standard MRSA eradication regimen led to a lasting eradication of the organism in 26 of 34 patients. MRSA infection occurred in two patients with no associated fatalities. CONCLUSION: Prospective monitoring revealed low rates of MRSA colonization and infection at our center. These low rates and the absence of patient-to-patient transmission support the effectiveness of the management bundle of MRSA identification, isolation, and decolonization. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-022-07140-0. Springer Berlin Heidelberg 2022-05-19 2022 /pmc/articles/PMC9385780/ /pubmed/35589879 http://dx.doi.org/10.1007/s00520-022-07140-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Füller, Miriam A.
Kampmeier, Stefanie
Wübbolding, Anna M.
Grönefeld, Judith
Kremer, Almut
Groll, Andreas H.
Prospective surveillance of colonization and disease by methicillin-resistant Staphylococcus aureus (MRSA) at a European pediatric cancer center
title Prospective surveillance of colonization and disease by methicillin-resistant Staphylococcus aureus (MRSA) at a European pediatric cancer center
title_full Prospective surveillance of colonization and disease by methicillin-resistant Staphylococcus aureus (MRSA) at a European pediatric cancer center
title_fullStr Prospective surveillance of colonization and disease by methicillin-resistant Staphylococcus aureus (MRSA) at a European pediatric cancer center
title_full_unstemmed Prospective surveillance of colonization and disease by methicillin-resistant Staphylococcus aureus (MRSA) at a European pediatric cancer center
title_short Prospective surveillance of colonization and disease by methicillin-resistant Staphylococcus aureus (MRSA) at a European pediatric cancer center
title_sort prospective surveillance of colonization and disease by methicillin-resistant staphylococcus aureus (mrsa) at a european pediatric cancer center
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385780/
https://www.ncbi.nlm.nih.gov/pubmed/35589879
http://dx.doi.org/10.1007/s00520-022-07140-0
work_keys_str_mv AT fullermiriama prospectivesurveillanceofcolonizationanddiseasebymethicillinresistantstaphylococcusaureusmrsaataeuropeanpediatriccancercenter
AT kampmeierstefanie prospectivesurveillanceofcolonizationanddiseasebymethicillinresistantstaphylococcusaureusmrsaataeuropeanpediatriccancercenter
AT wubboldingannam prospectivesurveillanceofcolonizationanddiseasebymethicillinresistantstaphylococcusaureusmrsaataeuropeanpediatriccancercenter
AT gronefeldjudith prospectivesurveillanceofcolonizationanddiseasebymethicillinresistantstaphylococcusaureusmrsaataeuropeanpediatriccancercenter
AT kremeralmut prospectivesurveillanceofcolonizationanddiseasebymethicillinresistantstaphylococcusaureusmrsaataeuropeanpediatriccancercenter
AT grollandreash prospectivesurveillanceofcolonizationanddiseasebymethicillinresistantstaphylococcusaureusmrsaataeuropeanpediatriccancercenter